Recent reports have demonstrated that CSRM617 [167], an SMI of OC2, and TH-302 [168], a hypoxia-activated prodrug, effectively induce cell death in PCa cell lines with high expression levels of OC2 and obviously inhibit tumor growth [32]. The gene discussed is ONECUT2; the disease is neoplasm.